Blister Pack Pharmaceutical Products Market - Global Industry Analysis

Blister Pack Pharmaceutical Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6482 Status : Upcoming

Description

Global Blister Pack Pharmaceutical Products Market: Overview

Blister packaging consists of polyvinyl chloride or polyethylene terephthalate plastic packaging. The rugged material utilized in blister packaging is ideal for diverse applications including toy production, manufacturing of electronic equipment, and packaging of pharmaceutical products. Blister packaging ensures product safety and protection. Moreover, it is cost-effective and the wider graphics area further boosts the sales footprint.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Blister Pack Pharmaceutical Products Market: Growth Factors

The steady demand from the pharma sector is one of the major factors driving the growth of the global blister pack pharmaceutical products market. Blister packaging is always a primary choice for pharmaceutical companies because of the convenience and benefits offered by monolayer and multilayer formats. Increasing expenditure on healthcare facilities coupled with the surging demand for the wide range of pharmaceutical drugs is inducing the companies to opt for outsourcing services through contract development. The manufacturing and contract developing organizations also facilitate services associated with active pharmaceutical production and product development along with packaging services. A majority of pharmaceutical tablets and capsules are packed in blister packaging format. Furthermore, packaging formats like jars, bottles, and containers are also common in the pharmaceutical sector to store, seal, and pack tablets & capsules. Blister packaging, being a sustainable packaging solution, is adopted by a wide number of businesses. The ongoing technological developments and innovations in pharmaceutical packaging solutions will further augment the sales of blister pack pharmaceutical products. The growing preference for unit dosing and small pack sizes is likely to support the growth of the market. However, the unit dosage allows the protection of the primary product from the risk of being contaminated for a long period of time and also keeps the rest of the product secured and sealed from external contaminants. Moreover, the leading market players are increasing their investments to boost the research and development activities in order to launch distinctive packaging solutions in the market. The prominent market leaders involved in the market are concentrating on forging strategic alliances along with launching sustainable and innovative blister pack pharmaceutical products to gain a competitive edge. Furthermore, the deployment and customization of new manufacturing techniques further enhance the quality and performance, which in turn is further likely to escalate the demand for blister pack pharmaceutical products in the forthcoming years.

Global Blister Pack Pharmaceutical Products Market: Segmentation

The global blister pack pharmaceutical products market can be segmented into end-user, technology, drug type, and region.

By end-user, the market can be segmented into veterinary drugs, nutraceuticals & supplements, and pharmaceuticals. The pharmaceutical segment accounts for the largest share in the global blister pack pharmaceutical products market due to its huge demand from packaging products like capsules and tablets.

By technology, the market can be segmented into thermoforming and cold forming technology. The thermoforming technology segment holds the largest share in the global blister pack pharmaceutical products market due to its capability to seal and pack a diverse range of pharmaceutical products at low manufacturing costs and faster speed.

By drug type, the market can be segmented into capsules and tablets.

Global Blister Pack Pharmaceutical Products Market: Regional analysis

North America accounts for the largest share in the global blister pack pharmaceutical products market due to the presence of prominent market leaders in the region. Moreover, the growing initiatives from the government to strengthen the healthcare infrastructure and associated services are likely to further promulgate the growth of the regional market in the forthcoming years.

Asia Pacific is anticipated to witness a significant growth rate during the forecast period due to the rapidly proliferating pharma sector in the region. Also, the ongoing technological advancements in the field of packaging products will further escalate the growth of the regional market.

Global Blister Pack Pharmaceutical Products Market: Competitive Players

Some of the significant players in the global blister pack pharmaceutical products market are Cadila Healthcare, etc., Sun Pharmaceutical Industries Ltd, Merck, Johnson & Johnson, Allergan, Novartis AG, Roche Holding AG, Sanofi, GlaxoSmithKline plc, and Pfizer Inc.

Global Blister Pack Pharmaceutical Products Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

The steady demand from the pharma sector is one of the major factors driving the growth of the global blister pack pharmaceutical products market. Blister packaging is always a primary choice for pharmaceutical companies because of the convenience and benefits offered by monolayer and multilayer formats. Increasing expenditure on healthcare facilities coupled with the surging demand for the wide range of pharmaceutical drugs is inducing the companies to opt for outsourcing services through contract development.

Some of the significant players in the global blister pack pharmaceutical products market are Cadila Healthcare, etc., Sun Pharmaceutical Industries Ltd, Merck, Johnson & Johnson, Allergan, Novartis AG, Roche Holding AG, Sanofi, GlaxoSmithKline plc, and Pfizer Inc.

 

North America accounts for the largest share in the global blister pack pharmaceutical products market due to the presence of prominent market leaders in the region. Moreover, the growing initiatives from the government to strengthen the healthcare infrastructure and associated services are likely to further promulgate the growth of the regional market in the forthcoming years.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social